RecruitingNCT06512194
Psilocybin with active, sham, or no vagus nerve stimulation for depression
About this title
Read the official source — NCT06512194Medication studyAges 18–70United States
Understand this study
Who could participate?
Listed age limits: 18 years to 70 years.
- Listed locations
- EdwardsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: May 13, 2025
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 141
- Sponsor
- Charles Raison
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Device, Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT06512194
- Official title
Show the full official title
An Investigation of Strategies to Understand and Optimize the Antidepressant Effects of Psilocybin (The OPTIMIZE Study)
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Edwards
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Charles Raison.
Does this study involve medication?
Yes. The study involves medication, including Psilocybin.
Who can participate?
Listed age limits: 18 years to 70 years.
Is this study still recruiting?
The registry lists this study as recruiting.
